Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Notice for cannabidiol (Jazz Pharmaceuticals ANZ Pty Ltd)
Active ingredients
cannabidiol
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
oral liquid solution
Indication
For adjunctive therapy of seizures associated with tuberous sclerosis complex (TSC) for patients 2 years of age and older
Therapeutic area
Neurology